Boehringer Ingelheim Withdraws Plans To Seek FDA Approval On AIDS Drug

03/25/2002 | Yahoo/Reuters

German drug maker Boehringer Ingelheim has announced it is scrapping plans to win U.S. approval to market an AIDS drug. Clinical trial data collected on Nevirapine, which appears to prevent mother-to-child transmission of AIDS, may not conform to FDA regulatory requirements, the National Institute for Allergies and Infectious Diseases said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX